Literature DB >> 26136532

Renal mineralocorticoid receptor and electrolyte homeostasis.

Andrew S Terker1, David H Ellison2.   

Abstract

The renal mineralocorticoid receptor (MR) is a steroid hormone receptor essential for maintaining electrolyte homeostasis. Its role in mediating effects of aldosterone was likely vital in enabling the evolution of terrestrial life. Dysregulated aldosterone-MR signaling has been identified as the cause of multiple clinical diseases, suggesting the physiological importance of the MR. While the physiology of this pathway has been studied for over 60 years, only more recently have genetic mouse models been available to dissect its function in vivo. This review will focus on recent advances in our knowledge of MR function with an emphasis on these models.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Na+ Cl− cotransporter; homeostasis; mineralocorticoid; potassium; sodium

Mesh:

Substances:

Year:  2015        PMID: 26136532      PMCID: PMC4839474          DOI: 10.1152/ajpregu.00135.2015

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  23 in total

1.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.

Authors:  J W Funder; P T Pearce; R Smith; A I Smith
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

2.  Immunolocalization of NAD-dependent 11 beta-hydroxysteroid dehydrogenase in human kidney and colon.

Authors:  Z Kyossev; P D Walker; W B Reeves
Journal:  Kidney Int       Date:  1996-01       Impact factor: 10.612

3.  Adrenal steroids stimulate thiazide-sensitive NaCl transport by rat renal distal tubules.

Authors:  H Velázquez; A Bartiss; P Bernstein; D H Ellison
Journal:  Am J Physiol       Date:  1996-01

4.  Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme.

Authors:  R E Smith; K X Li; R K Andrews; Z Krozowski
Journal:  Endocrinology       Date:  1997-02       Impact factor: 4.736

5.  Cloning, expression, and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11 beta-hydroxysteroid dehydrogenase.

Authors:  M Y Zhou; E P Gomez-Sanchez; D L Cox; D Cosby; C E Gomez-Sanchez
Journal:  Endocrinology       Date:  1995-09       Impact factor: 4.736

6.  Expression cloning of the aldosterone target cell-specific 11 beta-hydroxysteroid dehydrogenase from rabbit collecting duct cells.

Authors:  A Náray-Fejes-Tóth; G Fejes-Tóth
Journal:  Endocrinology       Date:  1995-06       Impact factor: 4.736

7.  Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.

Authors:  S Berger; M Bleich; W Schmid; T J Cole; J Peters; H Watanabe; W Kriz; R Warth; R Greger; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.

Authors:  S S Chang; S Grunder; A Hanukoglu; A Rösler; P M Mathew; I Hanukoglu; L Schild; Y Lu; R A Shimkets; C Nelson-Williams; B C Rossier; R P Lifton
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

Review 9.  Hyperkalemia: An adaptive response in chronic renal insufficiency.

Authors:  F John Gennari; Alan S Segal
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.

Authors:  R A Shimkets; D G Warnock; C M Bositis; C Nelson-Williams; J H Hansson; M Schambelan; J R Gill; S Ulick; R V Milora; J W Findling
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

View more
  10 in total

1.  High potassium promotes mutual interaction between (pro)renin receptor and the local renin-angiotensin-aldosterone system in rat inner medullary collecting duct cells.

Authors:  Chuanming Xu; Hui Fang; Li Zhou; Aihua Lu; Tianxin Yang
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-17       Impact factor: 4.249

2.  Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter.

Authors:  Lei Cheng; Søren Brandt Poulsen; Qi Wu; Cristina Esteva-Font; Emma T B Olesen; Li Peng; Björn Olde; L M Fredrik Leeb-Lundberg; Trairak Pisitkun; Timo Rieg; Henrik Dimke; Robert A Fenton
Journal:  J Am Soc Nephrol       Date:  2019-06-28       Impact factor: 10.121

3.  Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.

Authors:  Rajiv Agarwal; Amer Joseph; Stefan D Anker; Gerasimos Filippatos; Peter Rossing; Luis M Ruilope; Bertram Pitt; Peter Kolkhof; Charlie Scott; Robert Lawatscheck; Daniel J Wilson; George L Bakris
Journal:  J Am Soc Nephrol       Date:  2021-11-03       Impact factor: 10.121

4.  Acute Intravenous NaCl and Volume Expansion Reduces Sodium-Chloride Cotransporter Abundance and Phosphorylation in Urinary Extracellular Vesicles.

Authors:  Aihua Wu; Martin J Wolley; Qi Wu; Diane Cowley; Johan Palmfeldt; Paul A Welling; Robert A Fenton; Michael Stowasser
Journal:  Kidney360       Date:  2022-03-01

5.  Na+-Retaining Action of COX-2 (Cyclooxygenase-2)/EP1 Pathway in the Collecting Duct via Activation of Intrarenal Renin-Angiotensin-Aldosterone System and Epithelial Sodium Channel.

Authors:  Chuanming Xu; Guangrui Yang; Ziwei Fu; Yanting Chen; Shiying Xie; Fei Wang; Tianxin Yang
Journal:  Hypertension       Date:  2022-03-17       Impact factor: 9.897

6.  Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.

Authors:  Chunying Wu; Zhida Chen; Linlin Zhang; Yeyan Zhu; Mokan Deng; Cailin Huang; Yuting Liu; Qing Zhu; Lei Wang
Journal:  Hypertens Res       Date:  2020-09-09       Impact factor: 3.872

7.  Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies.

Authors:  Kenichi Shikata; Sadayoshi Ito; Naoki Kashihara; Masaomi Nangaku; Takashi Wada; Yasuyuki Okuda; Tomoko Sawanobori; Kotaro Sugimoto
Journal:  J Diabetes Investig       Date:  2022-04-21       Impact factor: 3.681

8.  Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect.

Authors:  Shuichi Ichikawa; Junko Tsutsumi; Kotaro Sugimoto; Satoru Yamakawa
Journal:  Adv Ther       Date:  2022-08-17       Impact factor: 4.070

9.  A retrospective analysis of postoperative hypokalemia in pituitary adenomas after transsphenoidal surgery.

Authors:  Lili You; Wenpeng Li; Tang Chen; Dongfang Tang; Jinliang You; Xianfeng Zhang
Journal:  PeerJ       Date:  2017-05-23       Impact factor: 2.984

10.  Aldosterone Decreases Vasopressin-Stimulated Water Reabsorption in Rat Inner Medullary Collecting Ducts.

Authors:  Yanhua Wang; Fuying Ma; Eva L Rodriguez; Janet D Klein; Jeff M Sands
Journal:  Cells       Date:  2020-04-14       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.